Current Therapeutic Research 1981;30(5):753-764
Although these medications are generally well-tolerated and safe, you should not take them if you: Are pregnant, breastfeeding, or plan on becoming pregnant Have a history of pancreatitis or thyroid cancer Are allergic to the active ingredient or any inactive ingredients in the drugs formulation Have multiple endocrine neoplasia (MEN) syndrome type 2 It is important to discuss any other medications you are taking with your healthcare provider to be sure there are not any serious drug interactions
10.1136/heartjnl-2019-315485 100 SongT
Conclusion Cu(II)-binding affinities for three major blood copper proteins: human serum albumin, ceruloplasmin and alpha-2-macroglobulin, were studied through their competition with a set of low-molecular weight Cu(II)-binding reference ligands (DTPA, EDTA, NTA, His) by using an unified LC-ICP MS-based approach
This combination enhances its ability to stimulate cellular repair processes and promote collagen production
Peeters F, Cassiman C, Van Keer K, Levtchenko E, Veys K, Casteels I (2019) Ophthalmic outcome in a Belgian cohort of cystinosis patients treated with a compounded preparation of cysteamine eye drops: retrospective analysis